Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is not a contraceptive and is not licensed or intended to prevent pregnancy. However, it affects how quickly your stomach empties, and that can reduce how well oral contraceptive pills are absorbed, particularly in the first weeks of treatment or after a dose increase. If you are using the pill and starting Mounjaro, the guidance on contraception and Mounjaro is worth reading before your first dose. These are prescription-only medicines and suitability is always decided by a prescriber who reviews your individual circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and the concern is legitimate. Mounjaro slows gastric emptying as part of how it reduces appetite. That slower transit means oral medications, including combined and progestogen-only contraceptive pills, may pass through the absorption window more quickly than usual or reach the small intestine later than expected. The practical result is that pill blood levels may be lower than they should be.
The MHRA's guidance, echoed by NHS Inform Scotland's published advice, is specific: if you take an oral contraceptive, add a reliable non-oral method such as condoms for the first four weeks of Mounjaro treatment and for four weeks after every dose increase. The reasoning is that tirzepatide's effect on gastric emptying is greatest at the start and when the dose steps up. It is not a theoretical risk dressed up in caution, it is a practical clinical instruction.
Injectable contraceptives, patches, vaginal rings, coils and implants do not depend on gut absorption, so they are not affected in the same way. If you are already using one of these methods, there is no equivalent instruction to add a barrier method. Your GP or prescriber can advise on the most suitable option for your circumstances, and if you are wondering whether drinking alcohol on Mounjaro is also something to reconsider, that is covered separately.
Mounjaro does not directly suppress ovulation. It has no hormonal contraceptive action. Women taking it can and do ovulate normally, and unintended pregnancy remains possible. In fact, some women find that significant weight reduction restores menstrual regularity or normalises cycles that had been disrupted by conditions such as polycystic ovary syndrome (PCOS), and that change can catch people off guard.
The NHS tirzepatide medicines page notes that tirzepatide should not be used during pregnancy and is not recommended if you are breastfeeding or trying to conceive. This is not a warning about Mounjaro causing harm to fertility as such, it reflects that safety data in pregnant women does not yet exist to the standard required for a positive recommendation. The precautionary position is therefore clear: stop before trying to conceive, and plan that with your prescriber.
If you are thinking about this in the context of unplanned pregnancy while on Mounjaro, the advice is to stop immediately and contact your GP. Do not continue without clinical guidance.
This is the part of the decision that requires a proper conversation rather than a quick read of a webpage. There is no universally agreed wash-out period published in UK guidance at the time of writing, but tirzepatide has a half-life of around five days, meaning it clears the body over several weeks after the last dose. Most prescribers advise stopping well in advance of attempting conception and discussing the timing of that with your GP or a specialist, and our guidance on getting pregnant on tirzepatide goes into that timing in more detail.
Weight regain after stopping is a real consideration. For many people, Mounjaro is treating a chronic condition, and pausing it to conceive and carry a pregnancy is a significant clinical decision, not just a practical one. More detail on pregnancy planning while on tirzepatide covers what to discuss at that appointment.
If you are considering Mounjaro as part of a broader weight-management plan and pregnancy is on your horizon, that context matters at the consultation stage. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally. You can start a free consultation and raise any questions about your personal circumstances directly with them.
The evidence base for tirzepatide in reproductive medicine is growing but not complete. NICE's appraisal of tirzepatide (TA1026) notes the not-recommended status in pregnancy without providing specific post-stopping intervals, reflecting the current state of the data. This is an area where clinical guidance is likely to evolve.
What is certain: Mounjaro is not a contraceptive, oral contraceptives may be less reliable on it without a backup method, and it should not be used during pregnancy or while trying to conceive. Beyond those clear points, the specifics depend on your contraception method, your cycle, your reproductive plans, and any underlying conditions. If you have already become pregnant while taking it, our page on being pregnant on Mounjaro explains what steps to take next.
Your GP remains the right first port of call for contraceptive advice alongside any prescription medicine. If you want to explore weight-loss treatment options more broadly, or have questions about how Mounjaro fits into your life right now, our clinical team is available seven days a week. And if you want to know more about how we work, our about page sets it out plainly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.